Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Share-based Compensation of $1.7 million for Q1 2025, down 26.21% year-over-year from $2.2 million in Q1 2024, and up 39.83% quarter-over-quarter from $1.2 million in Q4 2024.
Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Share-based Compensation for 9 consecutive years, with $1.7 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Share-based Compensation fell 26.21% year-over-year to $1.7 million; the TTM figure through Mar 2025 stood at $8.3 million (down 46.49% YoY), while the FY2026 annual figure was $5.3 million, down 35.85% from the prior year.
- Share-based Compensation advanced to $1.7 million in Q1 2025 per ACB's latest filing, from $1.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.8 million in Q4 2022 and bottomed at $1.2 million in Q4 2024.
- Historically, Share-based Compensation has averaged $3.0 million across 5 years, with a median of $2.7 million in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 153.81% — and 2023, when it plunged 73.34%.
- Aurora Cannabis' Share-based Compensation stood at $3.1 million in 2021, then jumped by 153.81% to $7.8 million in 2022, then slumped by 73.34% to $2.1 million in 2023, then slumped by 43.12% to $1.2 million in 2024, then soared by 39.83% to $1.7 million in 2025.
- Business Quant data shows ACB's Share-based Compensation at $1.7 million in Q1 2025, $1.2 million in Q4 2024, and $3.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 500,987.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Dec 31, 2022 | 7.82 Mn |
| Dec 31, 2022 | 7.82 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Jun 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 2.72 Mn |